StockData
IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV) stock

IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.84+0.24 (+0.09%)

Close on Nov 18, 2026Market cap $42.49BP/E 31.3Yield –

Iqvia operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Iqvia's operating income for the twelve months ending Sep 30, 2026 was $2.22B, up 1.7% year over year. For fiscal 2025 it was $2.18B, down 0.9% from the year before. Over ten years it grew 12.9% a year on average. The highest annual figure on record is $2.20B in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.18B-0.9%
FY2024Dec 31, 2024$2.20B+11.4%
FY2023Dec 31, 2023$1.98B+9.9%
FY2022Dec 31, 2022$1.80B+29.1%
FY2021Dec 31, 2021$1.39B+90.6%
FY2020Dec 31, 2020$731.00M-5.9%
FY2019Dec 31, 2019$777.00M+4.9%
FY2018Dec 31, 2018$741.00M+11.4%
FY2017Dec 31, 2017$665.00M+15.5%
FY2016Dec 31, 2016$576.00M-10.8%
FY2015Dec 31, 2015$646.00M+9.5%
FY2014Dec 31, 2014$590.00M+27.6%
FY2013Dec 31, 2013$462.33M+16.6%
FY2012Dec 31, 2012$396.44M+14.8%
FY2011Dec 31, 2011$345.25M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$572.00M+3.4%
Q2 FY2026Jun 30, 2026$506.00M0.0%
Q1 FY2026Mar 31, 2026$514.00M+3.6%
Q4 FY2025Dec 31, 2025$627.00M+0.2%
Q3 FY2025Sep 30, 2025$553.00M+0.5%
Q2 FY2025Jun 30, 2025$506.00M-2.7%
Q1 FY2025Mar 31, 2025$496.00M-2.0%
Q4 FY2024Dec 31, 2024$626.00M+25.0%
Q3 FY2024Sep 30, 2024$550.00M+14.3%
Q2 FY2024Jun 30, 2024$520.00M-0.8%
Q1 FY2024Mar 31, 2024$506.00M+7.4%
Q4 FY2023Dec 31, 2023$501.00M+32.2%
Q3 FY2023Sep 30, 2023$481.00M+1.9%
Q2 FY2023Jun 30, 2023$524.00M+15.7%
Q1 FY2023Mar 31, 2023$471.00M-4.8%
Q4 FY2022Dec 31, 2022$379.00M-18.1%
Q3 FY2022Sep 30, 2022$472.00M+56.3%
Q2 FY2022Jun 30, 2022$453.00M+58.4%
Q1 FY2022Mar 31, 2022$495.00M+44.7%
Q4 FY2021Dec 31, 2021$463.00M+60.2%
Q3 FY2021Sep 30, 2021$302.00M+61.5%
Q2 FY2021Jun 30, 2021$286.00M+361.3%
Q1 FY2021Mar 31, 2021$342.00M+77.2%
Q4 FY2020Dec 31, 2020$289.00M+74.1%
Q3 FY2020Sep 30, 2020$187.00M-8.3%
Q2 FY2020Jun 30, 2020$62.00M-68.5%
Q1 FY2020Mar 31, 2020$193.00M-8.1%
Q4 FY2019Dec 31, 2019$166.00M-19.8%
Q3 FY2019Sep 30, 2019$204.00M+12.7%
Q2 FY2019Jun 30, 2019$197.00M+15.9%
Q1 FY2019Mar 31, 2019$210.00M+14.8%
Q4 FY2018Dec 31, 2018$207.00M+45.8%
Q3 FY2018Sep 30, 2018$181.00M-7.2%
Q2 FY2018Jun 30, 2018$170.00M+34.9%
Q1 FY2018Mar 31, 2018$183.00M-9.4%
Q4 FY2017Dec 31, 2017$142.00M-1.4%
Q3 FY2017Sep 30, 2017$195.00M–
Q2 FY2017Jun 30, 2017$126.00M–
Q1 FY2017Mar 31, 2017$202.00M–
Q4 FY2016Dec 31, 2016$144.00M–

More Iqvia figures

See a number that looks wrong?